- Reagents and Kits
- Instruments
- Services
Infectious Disease Diagnostics Market size was valued at USD 15,380.6 million in 2022 and is poised to grow at a CAGR of 4.4% from 2023-2029. A diagnostic is a laboratory test used to diagnose infectious illnesses with the assistance of trained technicians and clinicians. Various diagnostic procedures and devices are used to test a sample of urine, blood, mucus, or other bodily fluids to determine the causing organism. Based on the disease type HIV/AIDS is anticipated to show a significant growth rate in the market share over the forecasting period. According to the World Health Organisation, infectious diseases such as HIV/AIDS are increasing significantly and in 2020 approximately 37 Mn population were living with HIV of which, 1.5 Mn people were newly infected. Moreover, in the USA, around 1.2 million people have HIV and out of this population 13 percent don’t know it and need testing. Moreover, the companies are focusing on launching new products to maintain growth in the market. The growing prevalence of infectious diseases, greater understanding of the diagnosis increases in government funding, rising healthcare costs and increasing adoption of technologically advanced diagnostic equipment in healthcare organizations also heighten the overall growth of the market.
Infectious Disease Diagnostics Market Key Developments:
- In May 2021, In May, Beckman Coulter commercialized Access SARS-CoV-2 IgG, a fully quantitative lab-based Immunoglobulin G (IgG) serology test that measures the quantity of antibodies against the virus that causes COVID-19
- In May 2022 Abbott launches HBsAg Next Assay in India for early detection of Hepatitis B.
Global Infectious Disease Diagnostics Market Summary
Study Period
2023-29
Base Year
2022
CAGR
4.4%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Infectious Disease Diagnostics Market Dynamics
The market is expected to rise as the number of medical laboratories practicing infectious disease diagnostic tests have been increased. Increased prevalence of infectious diseases such as hepatitis, influenza, COVID-19, and HIV, increased demand for infection diagnostic tests, increased funding from private and government organizations for diagnostic service centers, and advancements in infectious disease diagnostic technologies are anticipated to grow the market over the forecasting period. Moreover, rise in awareness about early stage disease diagnosis and government screening programs to lower the incidence rate and mortality are anticipated to burgeon the growth of the infectious disease diagnostics market over the forecast years.
North-America Got Significant Share
Infectious Disease Diagnostics Market Regional Analysis
The North America Infectious Disease Diagnostics Market was valued at USD 5,542.2 Million in 2018 and grown at 1.4% CAGR over the historic years to reach USD 6,395.2 Million in 2022 and poised to grow at 4.3% CAGR over the forecast period owing to the highly developed healthcare systems in the United States and Canada, as well as the presence of numerous prominent national clinical labs and easy access to technologically advanced instruments, have all contributed to the industry's success. USA accounted for revenue of USD 5,674.4 million and projected to grow at 4.3% CAGR over 2023 - 2029.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- Infectious Disease Diagnostics Market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Infectious Disease Diagnostics Market Segmentation
By Component
By Disease Type
- HIV
- HBV
- HCV
- TB
- HAIs
- Respiratory Infections
- STDs
- COVID-19
- Others
By Technology
- Immunoassay
- Molecular Diagnostics
By End User
- Hospitals and Clinics
- Diagnostic Centers
- Homecare
- Others
Frequently Asked Questions
The infectious disease diagnostics market size was valued at USD 15,380.6 million in 2022
The infectious disease diagnostics market's key players are: Abbott Laboratories Becton Dickinson and Company BioMerieus SA Bio-Rad Laboratories Danaher Corporation F Hoffman-La Roche Hologic Inc. Luminex Corporation Qiagen Inc Thermo Fisher Scientific Inc. LumiraDx
The infectious disease diagnostics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Infectious Disease Diagnostics Market Introduction |
| 2.1.Global Infectious Disease Diagnostics Market - Taxonomy |
| 2.2.Global Infectious Disease Diagnostics Market - Definitions |
| 2.2.1.Component |
| 2.2.2.Disease Type |
| 2.2.3.Technology |
| 2.2.4. End User |
| 2.2.5.Region |
| 3. Global Infectious Disease Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Infectious Disease Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Infectious Disease Diagnostics Market By Component, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Reagents and Kits |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Infectious Disease Diagnostics Market By Disease Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. HIV |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. HBV |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. HCV |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. TB |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. HAIs |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Respiratory Infections |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. STDs |
| 6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. COVID-19 |
| 6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 6.9. Others |
| 6.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.9.3. Market Opportunity Analysis |
| 7. Global Infectious Disease Diagnostics Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Immunoassay |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Molecular Diagnostics |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Infectious Disease Diagnostics Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospitals and Clinics |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Centers |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Homecare |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Global Infectious Disease Diagnostics Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Component Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Reagents and Kits |
| 10.1.2.Instruments |
| 10.1.3.Services |
| 10.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.HIV |
| 10.2.2.HBV |
| 10.2.3.HCV |
| 10.2.4.TB |
| 10.2.5.HAIs |
| 10.2.6.Respiratory Infections |
| 10.2.7.STDs |
| 10.2.8.COVID-19 |
| 10.2.9.Others |
| 10.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Immunoassay |
| 10.3.2.Molecular Diagnostics |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals and Clinics |
| 10.4.2.Diagnostic Centers |
| 10.4.3.Homecare |
| 10.4.4.Others |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Reagents and Kits |
| 11.1.2.Instruments |
| 11.1.3.Services |
| 11.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.HIV |
| 11.2.2.HBV |
| 11.2.3.HCV |
| 11.2.4.TB |
| 11.2.5.HAIs |
| 11.2.6.Respiratory Infections |
| 11.2.7.STDs |
| 11.2.8.COVID-19 |
| 11.2.9.Others |
| 11.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Immunoassay |
| 11.3.2.Molecular Diagnostics |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals and Clinics |
| 11.4.2.Diagnostic Centers |
| 11.4.3.Homecare |
| 11.4.4.Others |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Reagents and Kits |
| 12.1.2.Instruments |
| 12.1.3.Services |
| 12.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.HIV |
| 12.2.2.HBV |
| 12.2.3.HCV |
| 12.2.4.TB |
| 12.2.5.HAIs |
| 12.2.6.Respiratory Infections |
| 12.2.7.STDs |
| 12.2.8.COVID-19 |
| 12.2.9.Others |
| 12.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Immunoassay |
| 12.3.2.Molecular Diagnostics |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals and Clinics |
| 12.4.2.Diagnostic Centers |
| 12.4.3.Homecare |
| 12.4.4.Others |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Infectious Disease Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Reagents and Kits |
| 13.1.2.Instruments |
| 13.1.3.Services |
| 13.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.HIV |
| 13.2.2.HBV |
| 13.2.3.HCV |
| 13.2.4.TB |
| 13.2.5.HAIs |
| 13.2.6.Respiratory Infections |
| 13.2.7.STDs |
| 13.2.8.COVID-19 |
| 13.2.9.Others |
| 13.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Immunoassay |
| 13.3.2.Molecular Diagnostics |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals and Clinics |
| 13.4.2.Diagnostic Centers |
| 13.4.3.Homecare |
| 13.4.4.Others |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Infectious Disease Diagnostics Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Component Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Reagents and Kits |
| 14.1.2.Instruments |
| 14.1.3.Services |
| 14.2. Disease Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.HIV |
| 14.2.2.HBV |
| 14.2.3.HCV |
| 14.2.4.TB |
| 14.2.5.HAIs |
| 14.2.6.Respiratory Infections |
| 14.2.7.STDs |
| 14.2.8.COVID-19 |
| 14.2.9.Others |
| 14.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Immunoassay |
| 14.3.2.Molecular Diagnostics |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals and Clinics |
| 14.4.2.Diagnostic Centers |
| 14.4.3.Homecare |
| 14.4.4.Others |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Abbott Laboratories |
| 15.2.2.Becton Dickinson and Company |
| 15.2.3.BioMerieus SA |
| 15.2.4.Bio-Rad Laboratories |
| 15.2.5.Danaher Corporation |
| 15.2.6.F Hoffman-La Roche |
| 15.2.7.Hologic Inc. |
| 15.2.8.Luminex Corporation |
| 15.2.9.Qiagen Inc |
| 15.2.10.Thermo Fisher Scientific Inc. |
| 15.2.11.LumiraDx |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Abbott Laboratories
- Becton Dickinson and Company
- BioMerieus SA
- Bio-Rad Laboratories
- Danaher Corporation
- F Hoffman-La Roche
- Hologic Inc.
- Luminex Corporation
- Qiagen Inc
- Thermo Fisher Scientific Inc.
- LumiraDx